Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coasting vs GnRH Antagonist for OHSS Prevention in IVF/ICSI
NCT03996434Phase 4Completed
- Sponsor
- ClinAmygate
- Start
- Jul 2019
- Primary completion
- Nov 2019
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cetrorelix in ovarian hyperstimulation syndrome (OHSS), sponsored by ClinAmygate. Started Jul 2019; status: completed.
02
Drugs
cetrorelix
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT03996434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03996434.